| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,955 |
6,677 |
$355K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,057 |
4,193 |
$316K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,863 |
2,619 |
$206K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,784 |
5,230 |
$99K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,887 |
5,116 |
$79K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
634 |
574 |
$69K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,455 |
2,053 |
$58K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,325 |
1,141 |
$49K |
| 87428 |
|
1,040 |
937 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,094 |
4,300 |
$42K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,355 |
1,811 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,194 |
2,804 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
533 |
454 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
1,196 |
1,033 |
$18K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,372 |
4,730 |
$13K |
| 87807 |
|
712 |
611 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
684 |
586 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,953 |
1,679 |
$3K |
| 81002 |
|
1,263 |
1,115 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
16 |
13 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
997 |
868 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,750 |
2,370 |
$985.11 |
| 81025 |
|
320 |
285 |
$599.79 |
| 81003 |
|
74 |
51 |
$114.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
84 |
77 |
$110.93 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
34 |
31 |
$43.12 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
630 |
540 |
$0.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
681 |
585 |
$0.14 |
| 3079F |
|
78 |
69 |
$0.00 |
| 2010F |
|
396 |
349 |
$0.00 |
| 3074F |
|
353 |
303 |
$0.00 |
| 1170F |
|
667 |
568 |
$0.00 |
| 3008F |
|
539 |
462 |
$0.00 |
| 3080F |
|
25 |
24 |
$0.00 |
| 2001F |
|
531 |
469 |
$0.00 |
| 1160F |
|
538 |
474 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
349 |
330 |
$0.00 |
| 1159F |
|
539 |
475 |
$0.00 |
| 3078F |
|
244 |
209 |
$0.00 |
| 1494F |
|
390 |
346 |
$0.00 |
| 3077F |
|
12 |
12 |
$0.00 |